Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – October 4
4:47 AM MDT | October 4, 2011 | Deepti Ramesh
TAKEDA ACQUIRES NYCOMED FOR €9.6 BILLION Takeda Pharmaceutical (Osaka, Japan) says it has completed the acquisition of pharmaceuticals company Nycomed (Zurich, Switzerland) for €9.6 billion ($12.8 billion). Frank Morich has been named CEO of Nycomed, in addition to his current role as executive v.p./international operations at Takeda Pharmaceuticals International. Takeda has a strong presence in the Japanese and U.S. markets, while Nycomed has a significant business infrastructure in Europe and high-growth emerging markets that will enhance...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee